Ke Rui

Dr. Ke Rui

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2023 in Journal of Autoimmunity
Verified
Journal Article
Closed access
WHWei Huang
Wei Huang
KRKe Rui
Ke Rui
XWXiaomeng Wang
Xiaomeng Wang
NPNa Peng
Na Peng
WZWenhao Zhou
Wenhao Zhou
Jie TianJie Tian
Jie Tian

1 April 2022 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
YZYidan Zhang
Yidan Zhang
JTJie Tian
Jie Tian
FXFan Xiao
Fan Xiao
LZLeting Zheng
Leting Zheng
XZXiaoxia Zhu
Xiaoxia Zhu
LLLiwei Lu
Liwei Lu

1 April 2023 in Biomarker Research
Verified
Journal Article
Open access
PDF file
QYQingfang Yuan
Qingfang Yuan
NPNa Peng
Na Peng
FXFan Xiao
Fan Xiao
XSXiaofei Shi
Xiaofei Shi
BZBo Zhu
Bo Zhu
LLLiwei Lu
Liwei Lu
Interleukin-25 (IL-25), also known as IL-17E, is a cytokine belonging to the IL-17 family. IL-25 is abundantly expressed by Th2 cells and various kinds of epithelial cells. IL-25 is an alarm signal generated upon cell injury or tissue damage to activate immune cells through the interaction with IL-17RA and IL-17RB receptors. The binding of IL-25 to IL-17RA/IL-17RB complex not only initiates and maintains type 2 immunity but also regulates other immune cells (e.g., macrophages and mast cells) via various signaling pathways. It has been well-documented that IL-25 is critically involved in the development of allergic disorders (e.g., asthma). However, the roles of IL-25 in the pathogenesis of other diseases and the underlying mechanisms are still unclear. This review presents current evidence on the roles of IL-25 in cancers, allergic disorders, and autoimmune diseases. Moreover, we discuss the unanswered key questions underlying IL-25-mediated disease pathology, which will provide new insights into the targeted therapy of this cytokine in clinical treatment.

11 November 2022 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
PDF file
YWYanxia Wei
Yanxia Wei
NPNa Peng
Na Peng
CDChong Deng
Chong Deng
FZFutao Zhao
Futao Zhao
JTJie Tian
Jie Tian
LLLiwei Lu
Liwei Lu

29 January 2025 in Biomarker Research
Verified
Journal Article
Open access
PDF file
XWXiaomeng Wang
Xiaomeng Wang
YHYue Hong
Yue Hong
JZJinmei Zou
Jinmei Zou
BZBo Zhu
Bo Zhu
CJChao Jiang
Chao Jiang
KRKe Rui
Ke Rui
As a member of the Activator Protein-1 (AP-1) transcription factor family, the Basic Leucine Zipper Transcription Factor (BATF) mediates multiple biological functions of immune cells through its involvement in protein interactions and binding to DNA. Recent studies have demonstrated that BATF not only plays pivotal roles in innate and adaptive immune responses but also acts as a crucial factor in the differentiation and function of various immune cells. Lines of evidence indicate that BATF is associated with the onset and progression of allergic diseases, graft-versus-host disease, tumors, and autoimmune diseases. This review summarizes the roles of BATF in the development and function of innate and adaptive immune cells, as well as its immunoregulatory effects in the development of autoimmune diseases, which may enhance the current understanding of the pathogenesis of autoimmune diseases and facilitate the development of new therapeutic strategies.

14 September 2022 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
JLJUN LIU
JUN LIU
KRKe Rui
Ke Rui
NPNa Peng
Na Peng
HLHuiyan Luo
Huiyan Luo
BZBo Zhu
Bo Zhu
JTJie Tian
Jie Tian